Sana Biotechnology, Inc. (SANA)
3.135
+0.02
(+0.80%)
USD |
NASDAQ |
May 21, 15:15
Sana Biotechnology EPS Diluted (Quarterly) : -0.1705 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ImmunityBio, Inc. | -0.6162 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Beam Therapeutics, Inc. | -0.9134 |
| Prelude Therapeutics, Inc. | -0.1258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.21M |
| Total Expenses (Quarterly) | 47.21M |
| Enterprise Value | 835.48M |
| Earnings Yield | -29.95% |
| Normalized Earnings Yield | -23.79 |